Curewize Health Ltd.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of ProALL miRs in Blood Specimen for Prediction of ALL Relapse Risk (NCT03000335) | Curewize Health Ltd. | 2016-12-01 |
Track Curewize Health Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.